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Abstract
Lipocalins (LCNs) are members of a family of evolutionarily conserved genes present in all kingdoms of life. There are
19 LCN-like genes in the human genome, and 45 Lcn-like genes in the mouse genome, which include 22 major urinary
protein (Mup) genes. The Mup genes, plus 29 of 30 Mup-ps pseudogenes, are all located together on chromosome
(Chr) 4; evidence points to an “evolutionary bloom” that resulted in this Mup cluster in mouse, syntenic to the human
Chr 9q32 locus at which a single MUPP pseudogene is located. LCNs play important roles in physiological processes by
binding and transporting small hydrophobic molecules —such as steroid hormones, odorants, retinoids, and lipids—in
plasma and other body fluids. LCNs are extensively used in clinical practice as biochemical markers. LCN-like proteins
(18–40 kDa) have the characteristic eight β-strands creating a barrel structure that houses the binding-site; LCNs are
synthesized in the liver as well as various secretory tissues. In rodents, MUPs are involved in communication of
information in urine-derived scent marks, serving as signatures of individual identity, or as kairomones (to elicit fear
behavior). MUPs also participate in regulation of glucose and lipid metabolism via a mechanism not well understood.
Although much has been learned about LCNs and MUPs in recent years, more research is necessary to allow better
understanding of their physiological functions, as well as their involvement in clinical disorders.
Introduction
Lipocalins (LCNs) are members of a family that includes a
diverse group of low-molecular-weight (18–40 kDa) pro-
teins. The larger members of this family undergo cleavage
to form the ultimate LCN protein. Comprising usually
150–180 amino-acid residues, these proteins belong to the
calycin superfamily and are widely dispersed throughout
all kingdoms of life [1]. LCNs are evolutionarily conserved
and share an eight-stranded antiparallel β-sheet structure;
this forms a “barrel” which is the internal ligand-binding
site that interacts with and transports small hydrophobic
molecules—such as steroid hormones, odorants (e.g.,
pheromones), retinoids, and lipids [2, 3].
There are three main structurally conserved regions
(SCR1, SCR2, SCR3) that are shared in the lipocalin fold;
these represent a moiety composed of three loops that are
close to each other in the three-dimensional structure of
the β-strands that make up the barrel [4–7]. Based on the
SRCs, two separate groups have been proposed: the kernel
LCNs and the outlier LCNs [3]. The kernel LCNs repre-
sent a core set of proteins sharing the three characteristic
motifs, while the outlier LCNs, which are more divergent
family members, typically share only one or two motifs
[4]. Based on this categorization—retinoic acid-binding
protein-4 (RBP4), α1-microglobulin (A1M), apolipoprotein
D (APOD), complement C8 gamma chain (C8G), prosta-
glandin D2 synthase (PTGDS), and the major urinary pro-
teins (MUPs)—have all been classified as kernel lipocalins,
while odorant-binding proteins (OBP2A, OBP2B) and von
Ebner’s gland protein (LCN1) are included in the outlier
category [4, 7].
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Depending on the structure of the individual LCN, the
binding-site pocket can accommodate molecules of vari-
ous sizes and shapes—thus contributing to the diversity
of functions within this protein family [5]. Lipocalin
crystal structures confirm the highly conserved eight
continuously-hydrogen-bonded antiparallel β-strand do-
mains creating the barrel.
The fatty acid-binding protein (FABP) gene family is
considered a related, but distinct, subfamily of the
calycin superfamily [8] and will not be discussed fur-
ther here. Another subset of the lipocalins worthy of
mention is the immunocalin subfamily. These include
α1-acid glycoprotein, α1-microglobulin/bikunin pre-
cursor, and glycodelin, each of which exert significant
immunomodulatory effects in cell culture [9, 10];
interestingly, all three are encoded by genes in the hu-
man Chr 9q32-34 region—together with at least four
other lipocalins (neutrophil gelatinase-associated lipo-
calin, complement factor γ-subunit, tear prealbumin,
and prostaglandin D synthase), which also might exert
anti-inflammatory and/or antimicrobial activity [11].
Lipocalin family in humans
Among bacteria, plants, fungi, and animals, more than
1000 LCN genes have been identified to date. Nineteen
LCN genes, encoding functional LCN proteins, exist in the
human genome (Table 1). Figure 1 dendrogram shows the
evolutionary relatedness of these human LCN proteins.
In humans, LCNs are located in blood plasma and
other body fluids such as tears and genital secretions,
in which they serve as carriers for a variety of small
molecules [5]. LCNs also can play important roles in
disease such as diabetic retinopathy [12], and, as a re-
sult, they are extensively used clinically as biochemical
markers. For example, A1M (α1-microglobulin/biku-
nin precursor, encoded by the AMBP gene) is a bio-
marker of proteinuria and indicator of declining renal
function [13].
Lipocalin-1 (LCN1; human tear pre-albumin, or von
Ebner’s gland protein) is one of four major proteins in
human tears, acting as a lipid sponge on the ocular sur-
face [14, 15]. LCN1 is produced by lacrimal glands and
secreted into tear fluid. Decreased LCN1 levels are as-
sociated with Sjögren’s disease, LASIK-induced dry-eye
disease [16], and diabetic retinopathy [12].
Lipocalin-2 (LCN2; also known as neutrophil gelatinase-
associated lipocalin) mediates various inflammatory pro-
cesses by suppressing macrophage interleukin-10 (IL10)
production [17, 18]. Several studies have shown that
LCN2 gene expression in adipose tissue is elevated in
insulin-resistant states [19, 20]. LCN2 is also involved in
kidney development and used as a biomarker for acute
and chronic renal injury [21].
Odorant-binding proteins 2A and 2B (encoded by the
OBP2A and OBP2B genes) are members of the LCN family.
OBP2A is highly expressed in the oral sphere (e.g., nasal
mucus, salivary, and lacrimal glands), whereas OBP2B is
expressed in endocrine organs (e.g., mammary gland and
prostate) [22]. Functioning as soluble-carrier proteins,
OBP2A and OBP2B can bind reversibly to odorants [23].
The AMBP gene encodes α1-microglobulin/bikunin
precursor protein; α1-MG (A1M) is the lipocalin—de-
rived from proteolytic cleavage of AMBP [24]. A1M is
secreted into plasma, where it can exist free, or bound,
to immunoglobulin-A or albumin. Although the mo-
lecular weight of A1M is 27.0 kDa, it is freely filtered
through the glomerulus and reabsorbed by proximal
tubular cells [25]; for this reason, A1M is a biomarker
of proteinuria, i.e., increased levels in urine indicate a
defect in proximal tubules. A1M is considered to be a
major factor for progressive impairment of renal func-
tion, as well as for early diagnosis of acute allograft re-
jection [13, 24, 26]. Recent studies have shown A1M to
be expressed in rat retinal explants and to have oxygen
radical-scavenging and reductase properties; these find-
ings suggest that A1M might protect against oxidative
stress and possibly be involved in the response to ret-
inal detachment [27, 28].
Other members of the LCN family include apolipopro-
teins D (APOD) and M (APOM)—which interestingly ex-
hibit structural similarities to LCNs rather than to other
apolipoproteins. APOD is an atypical apolipoprotein, be-
cause it is highly expressed in mammalian tissues such as
liver, kidney, and central nervous system. APOD is a
component of HDL cholesterol. Recent studies have
shown that abnormal APOD expression is associated
with altered lipid metabolism; three distinct missense
mutations (Phe36Val, Tyr108Cys, and Thr158Lys) in
African populations link APOD with metabolic syndrome
[29]. A recent study showed that APOM, which resides in
the plasma HDL fraction, acts as a chaperone for sphingo-
sine-1-phosphate (S1P) and facilitates interaction between
S1P and plasma HDL, thereby exhibiting a vasculoprotec-
tive effect [30].
The protein encoded by the complement C8 gamma
chain gene (C8G) is one of the three subunits present in
complement component 8 (C8). It is an oligomeric protein
composed of three non-identical sub-units (α, 64-kDa; β,
64-kDa; γ, 22-kDa); the gamma chain is the only one that
belongs to the lipocalin family [31]. C8 is part of the
membrane-attack complex (MAC) that participates in
irreversible association of the complement proteins
C5b, C6, C7, and C9 to form a cytolytic complex that
inserts into, and directly lyses, microbes [32]. Activa-
tion of complement triggers the assembly of MAC,
which is then deployed to kill a wide range of
Gram-negative bacteria [33]. Two functionally distinct
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Table 1 List of all human LCN and mouse Lcn genes—with official gene symbols, full protein name, aliases, chromosomal locations,
isoforms, National Center for Biotechnology Information (NCBI) RefSeq mRNA accession numbers, NCBI RefSeq protein accession
numbers, and total number of amino acids (# of AAs) [information retrieved and confirmed from https://www.genenames.org/needs
a close bracket]
Gene
symbol
Full protein
name
Aliases Chromosome Isoforms Ref seq mRNA
number
Ref seq protein
number
No. of
AAs
LCN1 Lipocalin-1 isoform
1 precursor
TP; TLC; PMFA; VEGP 9q34 NM_001252617.1 NP_001239546 176
Lipocalin-1 isoform
2 precursor
9q34 NM_001252618.1 NP_001239547.1 233
Lipocalin-1 isoform
3 precursor
9q34 NM_001252619.1 NP_001239548.1 230
LCN2 Lipocalin-2 24p3; MSFI; NGAL 9q34 NM_005564.3 NP_005555.2 198
Lcn2 Lipocalin-2 NRL; 24p3; Sip24;
AW212229
2 NM_008491.1 NP_032517.1 200
Lcn3 Lipocalin-3 Vnsp1 2 NM_010694.1 NP_034824.1187 187
Lcn4 Lipocalin-4 Vnsp2; A630045M08Rik 2 NM_010695.1 NP_034825.1 185
Lcn5 Lipocalin-5 Erabp; MEP10; ERABP 2 Epididymal-specific
lipocalin-5 isoform X1
XM_006497665.1 XP_006497728.1 208
Epididymal-specific
lipocalin-5 isoform X2
XM_006497666.3 XP_006497729.1 202
Epididymal-specific
lipocalin-5 isoform X3
XM_006497667.2 XP_006497730.1 190
Epididymal-specific
lipocalin-5 isoform X4
XM_006497668.2 XP_006497731.1 190
Epididymal-specific
lipocalin-5 isoform X5
XM_006497669.1 XP_006497732.1 173
LCN6 Lipocalin-6 LCN5; hLcn5; UNQ643 9q34.3 NM_198946.2 NP_945184.1 163
Lcn6 Lipocalin-6 9230101D24Rik 2 Epididymal-specific
lipocalin-6 isoform
1 precursor;
NM_001276448.1 NP_001263377.1 245
Epididymal-specific
lipocalin-6 isoform
2 precursor
NM_177840.4 NP_808508.2 181
LCN8 Lipocalin-8 EP17; LCN5 9q34.3 NM_178469.3 NP_848564.2 152
Lcn8 Lipocalin-8 EP17; Lcn5; mEP17;
9230106L18Rik
2 NM_033145.1 NP_149157.1 175
LCN9 Lipocalin-9 HEL129; 9230102I19Rik 9q34.3 NM_001001676.1 NP_001001676.1 176
Lcn9 Lipocalin-9 9230102I19Rik 2 NM_029959.2 NP_084235.1 178
LCN10 Lipocalin-10 9q34.3 NM_001001712.2 NP_001001712.2 200
Lcn10 Lipocalin-10 9230112J07Rik 2 NM_178036.4 NP_828875.1 182
Lcn11 Lipocalin-11 Gm109 2 NM_001100455.2 NP_001093925.1 178
LCN12 Lipocalin-12 9q34.3 NM_178536.3 NP_848631.2 192
Lcn12 Lipocalin-12 9230102M18Rik 2 NM_029958.1 NP_084234.1 193
LCN15 Lipocalin-15 PRO6093; UNQ2541 9q34.3 NM_203347.1 NP_976222.1 184
Lcn15 Lipocalin-15 Gm33749 2 A3; 2 XM_006498514.1 XP_006498577.1 202
Lcn16 Lipocalin-16 Gm39773 2 XM_011239226.1 XP_011237528.1 181
Lcn17 Lipocalin-17 Gm39774 2 XM_011239227.1 XP_011237529.1 193
OBP2A Odorant binding
protein 2A
OBP; LCN13; OBP2C; OBPIIa;
hOBPIIa
9q34 NM_001293189.1 NP_001280118.1 228
Obp2a Odorant binding
protein 2A
Lcn13; BC027556 2 NM_153558.1 NP_705786.1 176
OBP2B Odorant-binding LCN14; OBPIIb 9q34 NM_001288987.1 NP_001275916.1 170
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C8-deficiency states have been identified: the first reflects
a lack of the alpha and gamma chains and has been re-
ported in Afro-Caribbean, Hispanic, and Japanese popula-
tions; the second results from lack of the beta chain and is
found mainly in Caucasians [34, 35]. Deficiency of C8
complement is a very rare primary immunodeficiency asso-
ciated with invasive and recurrent infections by Neisseria
meningitidis [32, 36, 37].
Orosomucoids (ORM1 and ORM2), α1-acid glycopro-
teins (trivial name AGPs), belong to the subfamily of
immunocalins. ORM1 is an acute phase protein secreted
by hepatocytes in response to inflammation, with its ex-
pression being regulated by pro-inflammatory cytokines
such as IL1 and IL6, the chemokine IL8, and glucocorti-
coids [38]. ORM1 and ORM2 are polymorphic proteins—
commonly referred to as ORM/AGP with four variants in
humans: AGP F1; AGP F2; AGP S, encoded by the ORM1
gene; and AGP A, encoded by the ORM2 gene [39]. AGPs
are important members of the lipocalin family, because
their capacity to bind to basic drugs can affect plasma free
drug concentrations, playing a key role in a drug’s volume
of distribution, metabolism, and therapeutic effect [40].
The ORM1 and ORM2 proteins have been recently identi-
fied as predictive urinary biomarkers for rheumatoid arth-
ritis [41]. In addition, they are predictive markers for
systemic lupus [42] and chronic inflammation [43].
Table 1 List of all human LCN and mouse Lcn genes—with official gene symbols, full protein name, aliases, chromosomal locations,
isoforms, National Center for Biotechnology Information (NCBI) RefSeq mRNA accession numbers, NCBI RefSeq protein accession
numbers, and total number of amino acids (# of AAs) [information retrieved and confirmed from https://www.genenames.org/needs
a close bracket] (Continued)
Gene
symbol
Full protein
name
Aliases Chromosome Isoforms Ref seq mRNA
number
Ref seq protein
number
No. of
AAs
protein-2B
Obp2b Odorant-binding
protein-2B
Lcn14 2 NM_001099301.1 NP_001092771.1 176
AMBP Alpha-1-microglobulin/
bikunin precursor
A1M; HCP; ITI; UTI; EDC1;
HI30; ITIL; IATIL; ITILC
9q32-q33 NM_001633.3 NP_001624.1 352
Ambp Alpha 1 microglobulin/
bikunin precursor
AI194774, ASPI, HI-30,
Intin4, Itil, UTI
4 B3; 4
33.96 cM
NM_007443.4 NP_031469.1 349
APOD Apolipoprotein D 3q29 NM_001647.3 NP_001638.1 189
Apod Apolipoprotein D 16 B2; 16
21.41 cM
NM_001301353.1 NP_001288282.1 189
APOM Apolipoprotein M G3a; NG20; apo-M;
HSPC336
6p21 NM_019101.2 NP_061974.2 188
Apom Apolipoprotein M G3a; NG20;
1190010O19Rik
17; 17 B1 NM_018816.1 NP_061286.1 190
C8G Complement component
8, gamma polypeptide
C8C 9q34.3 NM_000606.2 NP_000597.2 202
C8g Complement component
8, gamma polypeptide
2 A3; 2
17.31 cM
NM_001271777.1 NP_001258706.1 168
ORM1 Orosomucoid-1 ORM; AGP1; AGP-A;
HEL-S-153w
9q32 NM_000607.2 NP_000598.2 201
Orm1 Orosomucoid-1 Agp-1; Agp-2; Orm-1 4 B3; 4
33.96 cM
NM_008768.2 NP_032794.1 207
ORM2 Orosomucoid-2 AGP2; AGP-B; AGP-B 9q32 NM_000608.2 NP_000599.1 201
Orm2 Orosomucoid-2 Agp1; Orm-2 4 B3; 4
33.96 cM
NM_011016.2 NP_035146.1 207
PAEP Progestagen-associated
endometrial protein
GD; GdA; GdF; GdS; PEP;
PAEG; PP14
9q34 NM_001018049.1 NP_001018059.1 180
PTGDS Prostaglandin D2 synthase;
21 kDa (brain)
PDS; PGD2; PGDS; LPGDS;
PGDS2; L-PGDS
9q34.2-q34.3 NM_000954.5 NP_000945 190
Ptgds Prostaglandin D2 synthase;
21 kDa (brain)
PGD2; PGDS; 21 kDa;
PGDS2; Ptgs3; L-PGDS
2 A3; 2
17.28 cM
NM_008963.3 NP_032989.2 189
RBP4 Retinol-binding protein-4,
plasma
RDCCAS; MCOPCB10 10q23.33 NM_006744.3 NP_006735.2 201
Rbp4 Retinol-binding protein-4,
plasma
Rbp-4 19 C2; 19
32.75 cM
NM_001159487.1 NP_001152959.1 245
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The progestagen-associated endometrial protein (PAEP)
is a secreted immunosuppressive glycoprotein (28 kDa),
also termed glycodelin, i.e., one of the immunocalins. Stud-
ies have shown that PAEP downregulation can lead to abor-
tion during the first trimester—due to increased activation
of the immune system [44, 45]. In addition, PAEP has been
found expressed in many tumors (e.g., gynecological malig-
nancies, lung cancer, and melanoma) [46–48].
The protein encoded by the prostaglandin D2 synthase
(PTGDS) gene is a glutathione-independent prostaglandin
synthase (PTGDS). PTGDS is involved in the arachidonic
acid cascade, converting prostaglandin H2 to prostaglan-
din D2 (PGD2), and is preferentially expressed in brain
[49]. Increased PTGDS expression has been shown in pa-
tients having attention deficit hyperactivity disorder, com-
pared with patients having bipolar disorder [50]. Another
study suggests that dysregulated PTGDS mRNA expres-
sion is associated with rapid-cycling bipolar depression
[49]. Enhanced PTGDS expression has also been associ-
ated with various malignancies [51–55].
Plasma retinol-binding protein 4 (RBP4) is a 21-kDa
transporter of all-trans-retinol and belongs to the lipoca-
lin family [56, 57]. RBP4 circulates in plasma as a mod-
erately tight 1:1M complex with vitamin A. RBP4 is
secreted mainly by hepatocytes and also by adipose tis-
sue [58]. In humans, increased circulating RBP4 levels
have been correlated with obesity [59], insulin resistance,
and type-2 diabetes [60, 61]. Insulin resistance has been
long considered to play a key role in the development of
non-alcoholic fatty liver disease (NAFLD) [62]—which is
associated with altered RBP4 levels. Information in the
literature on this association, however, is controversial.
Several studies have reported significantly increased
RBP4 levels in patients with NAFLD [63–66], whereas
other studies have shown no difference on RBP4 levels
between control and NAFLD groups [67, 68].
There is limited information in the literature regarding
human LCN6, LCN8, LCN9, LCN10, LCN12, or LCN15.
Lipocalin family in mice
Lipocalins have been extensively studied in the mouse.
Forty-five proteins belong to this family in mice
(Table 1), which also includes major urinary proteins
(MUPs) as members of this family (Fig. 2). All of the
LCN genes are expressed in both humans and mice
(Table 1), with the only exception of LCN1, which is
found only in human—whereas Lcn3, Lcn4, Lcn5, Lcn11,
Lcn16, Lcn17, and all the functional Mup genes are
found in mouse but not human.
MUPs are intriguing small proteins (19–21 kDa) found
in mouse urine; in rats, MUPs are known as α2u-globulins
[69–72]. (For the purpose of this review, MUPs will refer
to major urinary proteins in both mouse and rat.) While
the presence of proteinuria is considered in humans to be
a pathological renal condition, this is not the case for mice
or rats [70]. Under physiological conditions, rodents ex-
crete substantial levels of protein in urine, with MUPs ac-
counting for > 90% of total protein content [70, 73, 74],
playing a key role in chemo-signaling between animals to
coordinate social behavior [75]. MUPs represent highly
homologous proteoforms that control the release of vola-
tile pheromones for urinary scent marks by transporting
them into the vomeronasal organ (VNO) [76, 77]. MUPs
bind pheromones within the hydrophobic calyx of the
protein structure where hydrophobic binding sites exist
for small lipophilic ligands. The affinity of each MUP for
specific ligands varies, according to its subtype [70, 78],
and depends on the amino-acid sequence in the binding
domain [79, 80]. MUP affinity is most affected by poly-
morphisms that influence amino acids on the luminal sur-
face of the ligand-binding domain (pocket)—rather than
on the protein surface where most sequence differences
are observed [73]. In addition, MUPs may act as direct
stimulants of pheromone receptors [81].
Fig. 1 Dendrogram of lipocalins (LCNs) in the human genome.
Although the names listed are the official human gene symbols
[https://www.genenames.org/], this dendrogram is based on the
alignment of proteins (listed in Table 1), using multiple sequence
alignment by CLUSTALW (http://www.genome.jp/tools/clustalw/)
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MUPs are primarily synthesized in post-pubescent
mouse liver in response to various hormones such as tes-
tosterone, growth hormone, thyroxine, insulin, and gluco-
corticoids [82, 83]. MUP synthesis is sex-dependent—
resulting in (three- to fourfold) higher protein concentra-
tions in post-pubescent males than female mice [84].
MUP expression is stimulated by androgens and leads
to higher expression levels in adult males than in fe-
males, as well as immature males [70, 85]. Because their
expression is stimulated by androgens, MUP synthesis
is gender-dependent with higher (three- to fourfold)
protein levels occurring in adult males than in females
or immature males [70, 85]. For example, in C57/BL6
mice, MUPs represent 3.5–4% of total protein synthe-
sized in male liver, but only 0.6–0.9% in female liver
[86]. Mup mRNA is also expressed in a number of
secretory tissues—such as nasal tissue, mammary, saliv-
ary, submaxillary, and lacrimal glands [87, 88]—as well
as skeletal muscle, kidney, brain, spleen, heart, epididy-
mal adipocytes, and brown adipose tissue [89–91].
MUP synthesis is initiated in response to different hor-
monal signals during various developmental stages; for
example, liver synthesis of MUPs begins at onset of pu-
berty and on through adulthood [92], whereas MUP
synthesis in lacrimal gland starts 1 to 2 weeks before
onset of puberty and continues into adulthood [83]. In
addition, the specific Mup mRNA subtype produced
varies from tissue to tissue [93] (Table 2).
The MUP gene cluster in mouse and human
genomes
Interestingly, the mouse Mup gene cluster (22 protein-cod-
ing genes; Table 3) can be divided into two subgroups. The
first group (Mup3, Mup4, Mup5, Mup6, Mup20, and
Mup21) is slightly older (Fig. 2) and contains a more diver-
gent class of genes. The second group comprises the
remaining 16 Mup genes, which share almost 99% se-
quence identity [75, 94]. The predicted gene, previously
designated Gm21320 (“gene model 21320”), has now been
renamedMup22, cf. [http://www.informatics.jax.org/].
As members of the LCN family, MUPs exhibit con-
servation in the common three-dimensional structure
of the protein family, i.e., a central area pocket formed
by eight hydrophobic β-strand domains that form a bar-
rel (Fig. 3) [81, 95]. This structure enables the MUPs to
serve as carrier proteins for small lipophilic molecules
such as pheromones and other chemical signals [78,
81]. All 22 mouse Mup protein-coding genes are lo-
cated in a cluster (the Mup locus) on Chr 4 (Fig. 4 a, b)
[96]. There are also 29 Mup-ps pseudogenes in the Chr
4 Mup cluster (intriguingly, the one remaining pseudo-
gene, Mup-ps22, is located on Chr 11).
An “evolutionary bloom” is defined when one sees a re-
cent, phylogenetically independent proliferation of close
paralogs or lineage-specific gene family expansion [97].
Examples of this phenomenon have been extensively stud-
ied in the large and diverse cytochrome P450 superfamily
[97]. For example, the koala’s ability to detoxify eucalyptus
Fig. 2 Dendrogram of mouse Lcn and Mup proteins. Although the
names listed are the official mouse gene symbols [http://
www.informatics.jax.org/], this dendrogram is based on the
alignment of proteins (listed in Tables 1 and 2), using multiple
sequence alignment by CLUSTALW (http://www.genome.jp/tools/
clustalw/)
Table 2 Mouse tissues known to express Mup mRNA [93]
Mup mRNA Tissue
Mup1 Liver
Mup2 Mammary gland, liver
Mup3 Liver
Mup4 Parotid gland, lacrimal gland,
nasal expression
Mup5 Submandibular gland, sublingual gland,
lacrimal gland
Mup6 Parotid gland
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Table 3 List of all mouse Mup genes [http://www.informatics.jax.org/], with official gene symbols, aliases, chromosomal locations, isoforms,
National Center for Biotechnology Information (NCBI) RefSeq mRNA accession numbers, NCBI RefSeq protein accession numbers, and total
number of amino acids (# of AAs) [information retrieved and confirmed from https://www.ncbi.nlm.nih.gov/genome.]
Gene
symbol
Aliases Chromosome Isoforms Ref seq mRNA
number
Ref seq protein
number
Full protein
name
No. of AAs
Mup1 Major urinary
protein-1
Mup7; Up-1; Ltn-1; Mup-1;
Mup-a; Mup10; Lvtn-1
4 MUP 1 isoform
b precursor
NM_001163010.1 NP_001156482.1 121
Mup2 Major urinary
protein-2
Mup4; Mup-2; AA589603 4 MUP 2 isoform
1 precursor
NM_001045550.2 NP_001039015.1 180
4 MUP 2 isoform 2 NM_001286096.1 NP_001273025.1 119
4 MUP 2 isoform
1 precursor
NM_008647.4 NP_032673.3 180
Mup3 Major urinary
protein-3
MUP15; Mup-3;
Mup25; MUPIII
4 MUP 3 precursor NM_001039544.1 NP_001034633.1 184
Mup4 Major urinary
protein-4
Mup1; Mup-4 4 MUP 4 precursor NM_008648.1 NP_032674.1 178
Mup5 Major urinary
protein-5
Mup18 4 MUP 5 precursor NM_008649.2 NP_032675.2 180
Mup6 Major urinary
protein-6
Mup2; Gm12544;
OTTMUSG00000007423
4 MUP (Mup)-like
precursor
NM_001081285.1 NP_001074754.1 179
Mup7 Major urinary
protein-7
Mup3; Gm12546;
OTTMUSG00000007428
4 MUP 7 precursor NM_001134675.1 NP_001128147.1 235
Mup8 Major urinary
protein-8
Mup5; Gm12809;
OTTMUSG00000008509
4 MUP 8 precursor NM_001134676.1 NP_001128148.1 235
Mup9 Major urinary
protein-9
Mup2; Mup6; Gm14076;
OTTMUSG00000015595
4 MUP 2-like precursor NM_001281979.1 NP_001268908.1 180
Mup10 Major urinary
protein-10
Mup8; 2610016E04Rik 4 MUP 10 precursor NM_001122647.1 NP_001116119.1 180
Mup11 Major urinary
protein-11
Gm12549;
OTTMUSG00000007431
4 MUP 11 precursor NM_001164526.1 NP_001157998.1 181
Mup12 Major urinary
protein-12
Gm2024 4 MUP 12 precursor NM_001199995.1 NP_001186924.1 180
Mup13 Major urinary
protein-13
Mup11; Gm13513;
OTTMUSG00000012492
4 MUP 13 precursor NM_001134674.1 NP_001128146.1 235
Mup14 Major urinary
protein-14
Mup12; Gm13514;
OTTMUSG00000012493
4 MUP 14 precursor NM_001199999.1 NP_001186928.1 180
Mup15 Major urinary
protein-15
Mup13; Gm2068 4 MUP 15 precursor NM_001200004.1 NP_001186933.1 180
Mup16 Major urinary
protein-16
4 MUP 16 precursor NM_001199936.1 NP_001186865.1 180
Mup17 Major urinary
protein-17
MUP 17; Gm12557;
OTTMUSG00000007480
4 MUP 17 precursor NM_001200006.1 NP_001186935.1 180
Mup18 Major urinary
protein-18
Mup6 4 MUP 6 precursor NM_001199333.1 NP_001186262.1 181
Mup19 Major urinary
protein-19
Mup8; Mup11; Mup14; Mup17; Gm12552;
100039247; OTTMUSG00000007472
4 MUP 11 and 8
precursor
NM_001135127.2 NP_001128599.1 180
Mup20 Major urinary
protein-20
Mup24; darcin; Gm12560;
OTTMUSG00000007485
4 MUP 20 precursor NM_001012323.1 NP_001012323.1 181
Mup21 Major urinary
protein-21
Mup; Mup26; Gm11208; bM64F17.1;
bM64F17.4; OTTMUSG00000000231
4 MUP 26 precursor NM_001009550.2 NP_001009550.1 181
Mup22 Major urinary
protein-22
Gm21320 4 MUP 2-like isoform
X1
XM_003688783.3 XP_003688831.1 181
Charkoftaki et al. Human Genomics           (2019) 13:11 Page 7 of 14
leaves appears to be due to an evolutionary bloom within
a cytochrome P450 gene group; the koala’s CYP2C sub-
family was found to comprise 31 putative protein-coding
functional enzymes, compared to 15 Cyp2c genes in
mouse and just four CYP2C genes in human [98]. Another
example is the mouse Scgb gene superfamily—which
includes a number of encoded androgen-binding proteins
involved in mate selection [99]; this is fascinating, because
the Mup cluster (described herein) also encodes proteins
involved in mate selection. It has been suggested that
these evolutionary blooms might represent simply a sto-
chastic process [97]. However, it is more likely these
blooms are the result of environmental pressures
needed for the organism to survive (i.e., find food, avoid
predators, and reproduce) at a particular moment in
evolutionary time.
Mup gene polymorphisms in rat and mouse have
shown significant differences. Yet, such differences have
not been seen in genomes of other mammalian species
for which whole-genome sequences have been explored
[75]. Although the amino acid sequence of MUP homo-
logs between rat and mouse is ~ 65%, there is a charac-
teristic six amino-acid consensus sequence (Glu-Glu-
Ala-Ser-Ser-Thr) that remains highly conserved be-
tween these two species [100]. In general, species differ-
ences in MUP proteins appear to be mainly due to
glycosylated MUP amino-acid residues that occur in
rats, but not mice [100]. Most other mammalian species
(e.g., dog, baboon, gorilla, and chimpanzee) have only one
functional protein-coding MUP gene, except for horse
that has three functional MUP genes [75].
The human MUP-related gene is a pseudogene
(MUPP, located at Chr 9q32). Using the UCSC genome
browser [https://genome.ucsc.edu/], one can visualize
that human Chr 9q32 is syntenic to mouse Chr 4 at
60,498,012Mb to 60,501,960Mb, where the Mup clus-
ter of 22 Mup genes is located; in fact, the human
ZFP37 and mouse Zfp37 gene flank the “MUP region”
in both human and mouse, respectively. The human
Fig. 3 Structure of prototypical mouse urinary protein. The crystal
structure consists of eight β-strands, forming a calyx-shaped barrel
(red); this encloses an internal ligand-binding site. There are also an
α-helix (green) and four 310-helices (blue); the hydrophobic pocket is
located inside the barrel. AB, BC, CD, DE, EF, FG, GH, HI, AND βI
denote the amino-acid segments between the β-strands (This
diagram taken from Ref. [95])
A
B
Fig. 4 Chromosomal location of mouse Mup genes and pseudogenes. a The Mup cluster region, located at 60,498,012 Mb to 60,501,960 Mb (red
vertical rectangle). Taken from the Ensembl genome browser. b The Chr 4 region (in greater detail)—showing ten of the 22 Mup genes (Gm21320
is Mup22) in the Mup cluster and 12 of the 29 Mup-ps pseudogenes
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MUPP locus exhibits a high degree of sequence similar-
ity to mouse Mup functional genes but contains
coding-sequence disruptions that prevent the gene
product from being formed [101]. The human MUPP
shows a G > A transition (relative to the chimpanzee
MUP sequence) that disrupts a splice-donor site [75];
this is interesting because this G > A mutation has not
been observed in mammals other than humans [101].
The human MUPP pseudogene sequence is most simi-
lar to the mouse Mup-ps4 pseudogene [75].
One of the main functions of MUP proteins is to pro-
mote aggressive behavior through binding to vomeronasal
pheromone receptors (V2Rs) in the accessory olfactory
neural pathway. Even though there is a co-expansion of
MUPs and V2Rs in mouse, rat, and opossum—all human
V2R receptors have become inactive, possibly leading to
the pseudogenization of the single human MUP gene [102,
103]. In other words, the absence of the specific V2R re-
moved the selection pressure for a functional MUP ligand.
Parallel expansions of Mup clusters
The last common ancestor of rat and mouse had either
a single, or a small number of, Mup genes [75]. By de-
termining the extent of Mup gene expansions across
non-rodent lineages, Logan and colleagues were able to
identify orthologs of the Slc46a2 and Zfp37 genes (and
the contiguous genomic sequence spanning the interval
between these two genes) in nine additional placental
mammals [75]. Whereas C57BL/6J mice have a cluster
of 22 distinct Mup genes on Chr 4 and rats have nine
distinct Mup genes, mammalian species such as dog,
pig, baboon, chimpanzee, bush baby, and orangutan—
each has a single Mup gene (with no evidence of add-
itional pseudogenes). By contrast, the human genome
has only the one pseudogene.
A neighbor-joining dendrogram of human LCN and
mouse MUP proteins is illustrated in Fig. 5; subfamilies
can be distinguished based on evolutionary divergence.
Note that all mouse MUPs are clustered into a subgroup
near the top of the dendrogram, whereas the human
LCNs are split into several different branches—due to
the high degree of divergence of LCN proteins. The
mouse Mup cluster divergence is most closely associated
with human LCN9 and PAEP (Fig. 5). Note that the evo-
lutionarily oldest human LCN genes include ORM1,
ORM2, APOM, APOD, RBP4, and LCN8.
Functions of MUPs in mice
MUPs and chemical communication
Due to their influence on pheromones, MUPs appear to
be involved in regulating transmission of social sig-
nals—such as identity, territorial marking, and mate
choice [104–106]. Most pheromones are small volatile
molecules that influence aggression, mating, feeding,
and territorial behavior within the same species [103,
107]. Mice use pheromones as cues to regulate social
behaviors. Neurons that detect pheromones reside in at
least two separate organs within the nasal cavity: the
vomeronasal organ (VNO) and the main olfactory epi-
thelium (MOE). Each pheromone molecule is thought
to activate a dedicated subset of these sensory neu-
rons—similar to the manner in which odorants are re-
ceived by dedicated subsets of mammalian olfactory
receptors. However, the identity of the responding neu-
rons that regulate specific social behaviors remains
largely unknown.
Pheromones have a short half-life, which can be pro-
longed by binding to the characteristic barrel pocket, in
the MUP protein. In addition, gradual release of a phero-
mone from a MUP protein allows the half-life of these
Fig. 5 Dendrogram of human LCNs and mouse MUPs, combined.
Although the names listed are the official human gene symbols and
mouse Mup gene symbols, this dendrogram was based on the
alignment of proteins (listed in Tables 1 and 3) using multiple
sequence alignment by CLUSTALW (http://www.genome.jp/tools/
clustalw/). Note that the human LCN9 gene is evolutionarily closest
to the mouse Mup cluster in this dendrogram
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airborne odor signals to be extended, e.g., to be used as
mammalian scent marks [108, 109].
MUPs are also linked to reproductive success in
males [110] and to social behavior, by adjusting the ani-
mal’s odor profile in response to different stimuli. This
function underscores how social environment plays an
important role in MUP production in both male and fe-
male mice. For example, MUP synthesis is upregulated
in a male mouse housed with a female, but downregu-
lated when a male mouse is housed with other males
only [111]. Perhaps related to this, MUPs can be pre-
dictive of the onset of aggressive and dispersal behavior
among male mice [103].
In addition to serving as pheromone carriers, MUPs
can function as pheromones themselves. They facilitate
chemical information exchange to convey specific infor-
mation (e.g., gender, social and reproductive status) be-
tween animals [70]. Recent research has revealed that
MUPs also act as kairomones, causing a fear reaction in
response to predators [112]. For example, the rat kairo-
mone that triggers defensive behavior in mice is encoded
by the Mup13 gene [112].
Members of the MUP family are known to be involved
in intraspecies interplay, especially male-male aggression
in mice [103]. Female mice are attracted to urine-borne
male pheromones. MUP20, for example, has been shown
to be rewarding and attractive to female mice. MUPs ex-
creted by male mice can also influence reproductive be-
havior and promote female attraction [103, 113–115].
The molecular mechanism promoting spontaneous ovu-
lation involves direct stimulation of VNO nerves by four
residues on the NH2-terminus of MUP proteins [116].
MUPs may also be involved in mediating individual rec-
ognition and inbreeding avoidance [117, 118].
MUPs and metabolism
MUPs also appear to be involved in energy metabolism—
actions reminiscent of the lipocalins that have been impli-
cated clinically in lipid disorders and metabolic syndrome
caused by obesity and type-2 diabetes [119, 120]. For ex-
ample, mouse MUP1 regulates systemic glucose metabol-
ism by modulating the hepatic gluconeogenic and/or
lipogenic programs [121–123]. Caloric restriction dramat-
ically reduces MUP1 expression in mouse liver [124, 125]
and appears to decrease MUP4 and MUP5 expression, as
well [124, 126].
Decreased hepatic MUP1 levels have been linked to
obesity and type-2 diabetes in mice with either genetic
(leptin receptor-deficient db/db) or dietary fat-induced
obesity [121, 127]. Similar decreases in MUP1 are found
in extrahepatic organs—such as adipose tissue and the
hypothalamus—after caloric restriction [128, 129]. Fur-
thermore, MUP1 was also found to lower blood glucose
levels by inhibiting expression of phosphoenolpyruvate
carboxykinase and glucose-6-phosphatase, two rate-lim-
iting enzymes for gluconeogenesis [127]. These studies
suggest that mouse MUP1, and possibly other MUP
family members, are playing key roles in energy metab-
olism and potentially contributing to the development of
metabolic diseases such as type-2 diabetes.
Human LCN-like genes and their mouse orthologs
We have listed the human LCN-related genes in Table 1
and mouse Lcn-like genes plus the Mup cluster genes
in Table 3. What are the percent similarities of pro-
teins—if one compares human LCN-like genes with
their mouse orthologs? Among the 19 LCN-like genes
in the human genome (Table 4), 17 have mouse ortho-
logs, whereas human LCN1 and PAEP do not. Within
the LCN cluster, LCN6 and LCN8 exhibit the highest
percent similarity: 74 and 70%, respectively. Among all
19 LCN-like genes, RBP4 and APOM reveal the highest
percent similarity (86% and 81%, respectively); LCN15
and OBP2A display the lowest percent similarity (39%)
to their mouse orthologs.
Human and mouse ancestors are estimated to have di-
verged from one another ~ 80 million years ago. Table 4
confirms the relatively rapid rate of evolutionary diver-
gence by the LCN-like genes, which is consistent with
Table 4 List of the 19 LCN-like genes in the human genome
and their similarity to their mouse orthologs, expressed as
percent identity (%)
Gene Similarity to mouse
(percent identity (%))
LCN1 NA
LCN2 62
LCN6 74
LCN8 70
LCN9 54
LCN10 64
LCN12 56
LCN15 39
OBP2A 39
OBP2B 50
AMBP 77
APOD 74
APOM 81
C8G 76
ORM1 49
ORM2 44
PAEP NA
PTGDS 72
RBP4 86
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their function of requiring evolutionarily quick adaptation
to changing environments; this is similar to, e.g., beta-
defensin (DEFB) genes, which number almost four dozen
in the human genome and encode broad-spectrum anti-
microbial cationic peptides [130]. Out of 19 LCN-like
genes, the appearance of two novel human genes (LCN1
and PAEP) during the past ~ 80 million years is further
evidence of an enhanced evolutionary rate for this gene
superfamily.
Rapid rates of evolutionary divergence stand in sharp
contrast to, e.g., highly conserved transcription factors,
whose human-mouse orthologs are generally > 95%
similar in protein sequence. In fact, assaying for com-
plementation of lethal growth defects in yeast, almost
half (47%) of the yeast genes could be successfully hu-
manized [131], and the yeast-human divergence oc-
curred well over one billion years ago.
Conclusions
Lipocalins (LCNs) are members of a family of evolu-
tionarily conserved small proteins that possess a bind-
ing pocket. The LCN proteins (18–40 kDa) are encoded
by 19 human LCN-related genes and 45 mouse Lcn-re-
lated genes. LCN proteins are expressed in numerous
tissues and play important roles in physiological pro-
cesses by transporting molecules in plasma and other
body fluids. In humans, LCNs are extensively used clin-
ically as biochemical markers in various diseases—such
as diabetic renal disease, systemic lupus erythematosus,
and chronic inflammation.
In mice, major urinary proteins (MUPs) are also mem-
bers of the lipocalin family. The Mup cluster of 22 func-
tional protein-coding Mup genes (plus 29 of 30 Mup-ps
pseudogenes) is confined to mouse Chr 4 and represents
an “evolutionary bloom,” because only one or a few
MUP genes are functional in other mammals. In fact, no
functional MUP gene exists in the human genome—al-
though a human MUPP pseudogene located at Chr 9q32
is syntenic to the Mup cluster on Chr 4.
The MUP protein structure contains a conserved “bar-
rel” formed by the eight β-chains having the characteris-
tic central hydrophobic pocket binding-site. Mouse
MUP proteins are expressed mainly in the liver, secreted
into the bloodstream, and excreted by the kidney. MUPs
are involved in the communication of information in
urine-derived scent marks and can also serve as phero-
mones themselves. Circulating MUPs may also contrib-
ute to regulation of nutrient metabolism—possibly by
suppressing hepatic gluconeogenic and lipid metabolism.
However, it still remains unclear how MUPs, especially
mouse MUP1, regulate energy metabolism and the glu-
coneogenic pathway. Further studies will be needed to
shed light on these mechanisms.
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